Talcum powder for children

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHILDREN'S POWDER (ASPERSIO PUERILIS)

Composition:

Active ingredient: zinc oxide;

1 g of powder contains zinc oxide 0.1 g;

Excipients: talc, potato starch.

Pharmaceutical form. Powder.

Main physico-chemical properties: soft, greasy to the touch powder of white or almost white color.

Pharmacotherapeutic group. Dermatological agents. Emollient and protective agents. Zinc preparations.

ATC code D02AB.

Pharmacological properties.

Pharmacodynamics.

An adsorbent, drying, antiseptic, and anti-inflammatory agent for topical use. It has high hygroscopicity, adsorbs secretions from sweat and sebaceous glands, exudate, reduces friction in skin folds, and protects the skin from adverse external influences.

Zinc oxide causes protein denaturation and formation of albuminates, which suppress local inflammatory processes, reduce pain sensations, constrict blood vessels, and strengthen cellular membranes. The preparation reduces the severity of local inflammatory and irritant manifestations.

Pharmacokinetics.

The components of the preparation do not penetrate through the skin and do not exert systemic effects.

Clinical characteristics.

Indications.

Warts.

Contraindications.

Hypersensitivity to the components of the drug, acute purulent skin diseases, weeping areas of the skin.

Safety precautions.

The drug should not be used for infected lesions and skin pustular diseases. The drug should not be applied to wet skin.

Improvement occurs after two or three applications of the drug. Avoid contact of the drug with eyes, respiratory tract, and open wound surfaces.

Interaction with other medicinal products and other forms of interaction.

Interaction with other medicinal products has not been established.

Instructions for use.

Use during pregnancy or breastfeeding.

The use of the drug during pregnancy or breastfeeding is possible only when the expected benefit to the mother outweighs the potential risk to the fetus or infant.

Ability to influence reaction rate when driving or operating machinery.

Does not affect.

Method of administration and dosage.

Apply externally. Apply the powder to dry areas affected by diaper rash after bathing and during diaper changes.

The duration of treatment depends on the course of the disease and is determined individually by a physician.

Children.

The medicinal product can be used in pediatric practice.

Overdose.

Overdose is unlikely with topical application. In case of accidental ingestion in large amounts, symptoms may include vomiting, diarrhea, central nervous system stimulation, and seizures.

Side effects.

Allergic reactions (itching, hyperemia, rash) are possible in case of hypersensitivity to the drug.

If any unusual reactions occur, the decision on further use of the drug should be reconsidered.

Shelf life.

5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C. Keep out of reach of children.

Packaging.

50 g in a polymer container.

50 g in a jar, 1 jar in a carton.

Availability.

Over-the-counter.

Manufacturer.

JSC "VITAMINS".

Manufacturer's location and address of business activity.

Ukraine, 20300, Cherkasy region, city of Uman, Uskenska Street, 31.

Marketing Authorization Holder.

JSC "VITAMINS".

Address of the Marketing Authorization Holder and/or its representative.

Ukraine, 20300, Cherkasy region, city of Uman, Uskenska Street, 31.